Concert Genetics
Karen Miller has a comprehensive work experience in the field of genetic counseling. Karen began their career as a Genetic Counselor at the University of Rochester in 1987 and worked there until 1998. In 2011, they returned to the University of Rochester as a Cancer Genetic Counselor and stayed there until 2019. During this time, they also worked at InformedDNA as a Genetic Analyst and later took on the role of Cancer Genetic Counselor. In 2022, Karen joined Concert Genetics as a Clinical Policy Analyst. Karen'sexpertise spans various aspects of genetic analysis and counseling, especially in the field of cancer genetics.
Karen Miller attended the University of Rochester from 1981 to 1985, where they pursued a Bachelor of Science degree in Molecular Genetics. Following this, from 1985 to 1986, they furthered their education at the University of Michigan, where they obtained a Master of Science degree in Human Genetics/Genetic Counseling.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.